Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.

Saved in:
Bibliographic Details
Title: Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
Authors: Baxter JS; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Brough R; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Krastev DB; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Song F; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Sridhar S; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Gulati A; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Alexander J; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Roumeliotis TI; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Kozik Z; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Choudhary JS; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Haider S; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Pettitt SJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Tutt ANJ; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Lord CJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Source: Molecular oncology [Mol Oncol] 2024 Feb; Vol. 18 (2), pp. 369-385. Date of Electronic Publication: 2023 Oct 22.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.13537